Our previous studies demonstrated that pharmacological blockade or depletion of MRTFs or their target genes Myoferlin or Tetraspanin 5 inhibits HCC growth by inducing oncogene-induced senescence [3, 8, 10, 11]. The gene discussed is TSPAN5; the disease is hepatocellular carcinoma.